Analgesics is recording a more regular performance again in 2021, after experiencing an atypical year in 2020 due to the event of the pandemic. For example, acetaminophen is seeing slower growth compared to 2020, caused by a sudden drop in sales in mid-2020 following significant stockpiling during the earlier winter months of the year and during the start of the COVID-19 pandemic. However, due to second and third waves of the virus through 2021, sales remain in positive figures. A further impact...

Euromonitor International’s Analgesics in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.